Compare Invesco Ltd. (IVZ) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Invesco Ltd. vs Tempus AI — how do they compare? Invesco Ltd. trades at $31.16 (market cap $14.01B), while Tempus AI trades at $55.61 (market cap $9.93B). The key difference: Invesco Ltd. is the larger of the two by market cap, and Invesco Ltd. pays a 2.71% dividend while Tempus AI pays none. Which is the better fit depends on your goals.
| IVZ | TEM | |
|---|---|---|
Market Cap | $14.01B | $9.93B |
Sector | Financials | Broad Market / Factor |
52-Week High | $32.01 | $103.25 |
52-Week Low | $20.67 | $41.55 |
Enterprise Value | $24.18B | $10.56B |
Dividend Yield | 2.71% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Invesco (IVZ) trades at $31.58, near its 52-week high, with a bullish technical signal from moving averages and recent record inflows driving AUM growth. The company reported mixed quarterly EPS results but shows improving cash flow trends, with 2025 operating cash flow at $1.53 billion. Analyst consensus is divided, with 42.9% buy ratings and a $32.50 price target, while negative net income margins and ROE highlight profitability challenges.
The outlook is cautiously optimistic due to strong institutional interest and dividend consistency, but risks include expense pressures and volatile earnings. Investors should weigh the bullish technicals and asset growth against fundamental weaknesses in profitability and margin compression.
Tempus AI (TEM) trades at $52.05, up 12.86% in 24 hours, reflecting strong momentum after Q2 2026 earnings beat revenue estimates and raised 2026 sales guidance. The stock is technically bullish with moving averages supporting upside, while fundamentals show revenue growth to $1.4 billion in 2026 but persistent net losses. Recent news highlights expansion through the Personalis acquisition and AI-driven precision medicine advancements.
Outlook: Growth prospects are robust with AI adoption in healthcare and strategic deals, but high valuation ratios and negative profitability pose risks. Analysts are bullish with a $61.57 consensus target, though cash burn and competitive pressures require monitoring for sustained investor confidence.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Invesco Ltd.
Invesco provides investment-management services to retail (65% of managed assets) and institutional (35%) clients. At the end of August 2022, the firm had $1.416 trillion in assets under management spread among its equity (47% of AUM), balanced (5%), fixed-income (22%), alternative investment (14%), and money market (12%) operations. Passive products account for 32% of Invesco's total AUM, including 56% of the company's equity operations and 13% of its fixed-income platform. Invesco's U.S. retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside the U.S., with close to one third of its AUM sourced from Canada (2%), the U.K. (4%), continental Europe (11%), and Asia (15%).
Read more on IVZ →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
